We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stem Cells Derived by Parthenogenesis

By Biotechdaily staff writers
Posted on 21 May 2002
Specialized cell types, including heart and brain cells, have been developed from embryonic monkey stem cells through parthenogenesis by researchers at Advanced Cell Technology (ACT, Worcester, MA, USA) and Wake Forest University School of Medicine (Winston-Salem, NC, USA). The research was reported in the January 31, 2002, issue of Science.

Pathenogenesis is a process by which embryonic development is initiated directly from an unfertilized egg cell, so no fetus develops. The process may avoid the controversy associated with using embryonic stem cells. The researchers generated a pluripotent stem cell line, from which they have produced neurons, heart muscle, smooth muscle, and other kinds of cells. The cell line has grown continuously for 10 months. Potential applications include the treatment of disease where specific cell types have become dysfunctional, such as heart disease, diabetes, and Parkinson's disease. Cells derived from this renewable source might be able to alleviate some technical problems of human cell therapy, say the researchers.

The most remarkable differentiation was the development of midbrain dopamine neurons. "This is a special population of neurons whose efficient generation from primate embryonic stem cells had not been reported previously,” noted Drs. Grant and Vrana, both professors of physiology and pharmacology at Wake Forest.





Related Links:
Univ. of Wake Forest
Advanced Cell Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automated Urinalysis Solution
UN-9000

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
21 May 2002  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
21 May 2002  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
21 May 2002  |   BioResearch